Skip to main content

Advertisement

SpringerLink
Log in

Morbidity and Mortality of Large-Vessel Vasculitides

  • Recent Advances in Large Vessel Vasculitis ( C Dejaco and C Duftner, Section Editors)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Giant cell arteritis (GCA) and Takayasu arteritis (TAK) comprise the primary systemic large-vessel vasculitides. In these conditions, arterial stenosis, occlusion, aneurysm, and dissection can lead to severe disease-related consequences. This review focuses on disease-related manifestations of GCA and TAK, emphasizing the impact of these findings on long-term morbidity and mortality.

Recent Findings

Vision loss remains a main contributor of morbidity in GCA. Non-invasive imaging allows for recognition of aortic disease in GCA but monitoring and intervention guidelines require further development. TAK represents a severe disease of early-onset with high risk of morbidity due to aortic, pulmonary, cardiovascular, and neurologic involvement. Overall, patients with GCA have similar mortality rates to comparators but mortality is notably higher than the general population in TAK.

Summary

A multidisciplinary approach of expert subspecialists is required to assist with the complex care of patients with GCA and TAK in order to appropriately surveil, identify, and address the multi-faceted co-morbidities of these diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol. 1998;125(4):509–20. https://doi.org/10.1016/s0002-9394(99)80192-5.

    Article  CAS  PubMed  Google Scholar 

  2. Chen JJ, Leavitt JA, Fang C, Crowson CS, Matteson EL, Warrington KJ. Evaluating the incidence of arteritic ischemic optic neuropathy and other causes of vision loss from giant cell arteritis. Ophthalmology. 2016;123(9):1999–2003. https://doi.org/10.1016/j.ophtha.2016.05.008.

    Article  PubMed  Google Scholar 

  3. Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology. 1994;101(11):1779–85. https://doi.org/10.1016/s0161-6420(94)31102-x.

    Article  CAS  PubMed  Google Scholar 

  4. Baldursson O, Steinsson K, Bjornsson J, Lie JT. Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum. 1994;37(7):1007–12. https://doi.org/10.1002/art.1780370705.

    Article  CAS  PubMed  Google Scholar 

  5. Glutz von Blotzheim S, Borruat FX. Neuro-ophthalmic complications of biopsy-proven giant cell arteritis. Eur J Ophthalmol. 1997;7(4):375–82.

    Article  CAS  PubMed  Google Scholar 

  6. Dare B, Byrne E. Giant cell arteritis. A five-year review of biopsy-proven cases in a teaching hospital. Med J Aust. 1980;1(8):372–3.

    Article  CAS  PubMed  Google Scholar 

  7. Bengtsson BA, Malmvall BE. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. Arthritis Rheum. 1981;24(7):899–904. https://doi.org/10.1002/art.1780240706.

    Article  CAS  PubMed  Google Scholar 

  8. Font C, Cid MC, Coll-Vinent B, Lopez-Soto A, Grau JM. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br J Rheumatol. 1997;36(2):251–4. https://doi.org/10.1093/rheumatology/36.2.251.

    Article  CAS  PubMed  Google Scholar 

  9. Salvarani C, Cimino L, Macchioni P, Consonni D, Cantini F, Bajocchi G, et al. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum. 2005;53(2):293–7. https://doi.org/10.1002/art.21075.

    Article  PubMed  Google Scholar 

  10. Cid MC, Font C, Oristrell J, de la Sierra A, Coll-Vinent B, Lopez-Soto A, et al. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum. 1998;41(1):26–32. https://doi.org/10.1002/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0.

    Article  CAS  PubMed  Google Scholar 

  11. Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol. 1998;125(4):521–6. https://doi.org/10.1016/s0002-9394(99)80193-7.

    Article  CAS  PubMed  Google Scholar 

  12. Loddenkemper T, Sharma P, Katzan I, Plant GT. Risk factors for early visual deterioration in temporal arteritis. J Neurol Neurosurg Psychiatry. 2007;78(11):1255–9. https://doi.org/10.1136/jnnp.2006.113787.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Singh AG, Kermani TA, Crowson CS, Weyand CM, Matteson EL, Warrington KJ. Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort. J Rheumatol. 2015;42(2):309–15. https://doi.org/10.3899/jrheum.140188.

    Article  PubMed  Google Scholar 

  14. Diamantopoulos AP, Haugeberg G, Lindland A, Myklebust G. The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis? Rheumatology (Oxford). 2016;55(1):66–70. https://doi.org/10.1093/rheumatology/kev289.

    Article  Google Scholar 

  15. Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100(4):550–5. https://doi.org/10.1016/s0161-6420(93)31608-8.

    Article  CAS  PubMed  Google Scholar 

  16. Liddle J, Bartlam R, Mallen CD, Mackie SL, Prior JA, Helliwell T, et al. What is the impact of giant cell arteritis on patients’ lives? A UK qualitative study. BMJ Open. 2017;7(8):e017073. https://doi.org/10.1136/bmjopen-2017-017073.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Renaud J, Bedard E. Depression in the elderly with visual impairment and its association with quality of life. Clin Interv Aging. 2013;8:931–43. https://doi.org/10.2147/CIA.S27717.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Agard C, Barrier JH, Dupas B, Ponge T, Mahr A, Fradet G, et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum. 2008;59(5):670–6. https://doi.org/10.1002/art.23577.

    Article  PubMed  Google Scholar 

  19. Prieto-Gonzalez S, Arguis P, Garcia-Martinez A, Espigol-Frigole G, Tavera-Bahillo I, Butjosa M, et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis. 2012;71(7):1170–6. https://doi.org/10.1136/annrheumdis-2011-200865.

    Article  PubMed  Google Scholar 

  20. Evans JM, O’Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Int Med. 1995;122(7):502–7. https://doi.org/10.7326/0003-4819-122-7-199504010-00004.

    Article  CAS  PubMed  Google Scholar 

  21. O’Neill L, Molloy ES. The role of toll like receptors in giant cell arteritis. Rheumatology (Oxford). 2016;55(11):1921–31. https://doi.org/10.1093/rheumatology/kew001.

    Article  CAS  Google Scholar 

  22. Hoffman GS. Large-vessel vasculitis: unresolved issues. Arthritis Rheum. 2003;48(9):2406–14. https://doi.org/10.1002/art.11243.

    Article  PubMed  Google Scholar 

  23. Robson JC, Kiran A, Maskell J, Hutchings A, Arden N, Dasgupta B, et al. The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK. Ann Rheum Dis. 2015;74(1):129–35. https://doi.org/10.1136/annrheumdis-2013-204113.

    Article  PubMed  Google Scholar 

  24. Gonzalez-Gay MA, Garcia-Porrua C, Pineiro A, Pego-Reigosa R, Llorca J, Hunder GG. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore). 2004;83(6):335–41. https://doi.org/10.1097/01.md.0000145366.40805.f8.

    Article  Google Scholar 

  25. •• de Boysson H, Daumas A, Vautier M, Parienti JJ, Liozon E, Lambert M, et al. Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients. Autoimmun Rev. 2018;17(4):391–8. https://doi.org/10.1016/j.autrev.2017.11.029Comparison of patients with GCA with different phenotypic presentations is typically limited due to cohort size. This large multicenter retrospective study highlights key differences between patients with GCA and large-vessel involvement to those with GCA but without LVI at diagnosis. In addition, follow-up imaging was performed in a notable subset of patients and risk factors for the development of incident aortic disease are identified.

    Article  PubMed  Google Scholar 

  26. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48(12):3522–31. https://doi.org/10.1002/art.11353.

    Article  PubMed  Google Scholar 

  27. Garcia-Martinez A, Arguis P, Prieto-Gonzalez S, Espigol-Frigole G, Alba MA, Butjosa M, et al. Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation). Ann Rheum Dis. 2014;73(10):1826–32. https://doi.org/10.1136/annrheumdis-2013-203322.

    Article  PubMed  Google Scholar 

  28. Liu G, Shupak R, Chiu BK. Aortic dissection in giant-cell arteritis. Semin Arthritis Rheum. 1995;25(3):160–71. https://doi.org/10.1016/s0049-0172(95)80028-x.

    Article  CAS  PubMed  Google Scholar 

  29. Kebed DT, Bois JP, Connolly HM, Scott CG, Bowen JM, Warrington KJ, et al. Spectrum of aortic disease in the giant cell arteritis population. Am J Cardiol. 2018;121(4):501–8. https://doi.org/10.1016/j.amjcard.2017.11.011.

    Article  PubMed  Google Scholar 

  30. •• Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77(5):636–43. https://doi.org/10.1136/annrheumdis-2017-212649There is considerable uncertainty about the timing, type, and utility of imaging to employ in the evaluation of patients with large-vessel vasculitis. An international group of experts provide guidance for clinicians evaluating these patients. A total of 12 recommendations have been formulated, including a general recommendation that imaging should be performed early in the disease course in patients with suspected LVV. Ultrasound and MRI are the first choices in GCA and TAK, respectively; CT or PET may be used alternatively.

    Article  PubMed  Google Scholar 

  31. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation. 2010;121(13):e266–369. https://doi.org/10.1161/CIR.0b013e3181d4739e.

    Article  PubMed  Google Scholar 

  32. Bienvenu B, Ly KH, Lambert M, Agard C, Andre M, Benhamou Y, et al. Management of giant cell arteritis: recommendations of the French Study Group for Large Vessel Vasculitis (GEFA). Rev Med Int. 2016;37(3):154–65. https://doi.org/10.1016/j.revmed.2015.12.015.

    Article  CAS  Google Scholar 

  33. Kermani TA, Crowson CS, Muratore F, Schmidt J, Matteson EL, Warrington KJ. Extra-cranial giant cell arteritis and Takayasu arteritis: how similar are they? Semin Arthritis Rheum. 2015;44(6):724–8. https://doi.org/10.1016/j.semarthrit.2015.01.005.

    Article  PubMed  Google Scholar 

  34. Grayson PC, Maksimowicz-McKinnon K, Clark TM, Tomasson G, Cuthbertson D, Carette S, et al. Distribution of arterial lesions in Takayasu’s arteritis and giant cell arteritis. Ann Rheum Dis. 2012;71(8):1329–34. https://doi.org/10.1136/annrheumdis-2011-200795.

    Article  PubMed  Google Scholar 

  35. Sujobert P, Fardet L, Marie I, Duhaut P, Cohen P, Grange C, et al. Mesenteric ischemia in giant cell arteritis: 6 cases and a systematic review. J Rheumatol. 2007;34(8):1727–32.

    PubMed  Google Scholar 

  36. Scola CJ, Li C, Upchurch KS. Mesenteric involvement in giant cell arteritis. An underrecognized complication? Analysis of a case series with clinicoanatomic correlation. Medicine (Baltimore). 2008;87(1):45–51. https://doi.org/10.1097/MD.0b013e3181646118.

    Article  Google Scholar 

  37. Muratore F, Kermani TA, Crowson CS, Green AB, Salvarani C, Matteson EL, et al. Large-vessel giant cell arteritis: a cohort study. Rheumatology (Oxford). 2015;54(3):463–70. https://doi.org/10.1093/rheumatology/keu329.

    Article  Google Scholar 

  38. Gonzalez-Gay MA, Pineiro A, Gomez-Gigirey A, Garcia-Porrua C, Pego-Reigosa R, Dierssen-Sotos T, et al. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore). 2004;83(6):342–7. https://doi.org/10.1097/01.md.0000145369.25558.b5.

    Article  Google Scholar 

  39. Assie C, Janvresse A, Plissonnier D, Levesque H, Marie I. Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: a series of 36 patients. Medicine (Baltimore). 2011;90(1):40–51. https://doi.org/10.1097/MD.0b013e318206af16.

    Article  Google Scholar 

  40. Czihal M, Tato F, Rademacher A, Kuhlencordt P, Schulze-Koops H, Hoffmann U. Involvement of the femoropopliteal arteries in giant cell arteritis: clinical and color duplex sonography. J Rheumatol. 2012;39(2):314–21. https://doi.org/10.3899/jrheum.110566.

    Article  PubMed  Google Scholar 

  41. Kermani TA, Matteson EL, Hunder GG, Warrington KJ. Symptomatic lower extremity vasculitis in giant cell arteritis: a case series. J Rheumatol. 2009;36(10):2277–83. https://doi.org/10.3899/jrheum.090269.

    Article  PubMed  Google Scholar 

  42. McLachlan RHP, Lennox AF, Varcoe RL, Thomas SD. Endovascular treatment of critical lower limb ischemia caused by giant cell arteritis. J Vasc Surg Cases Innov Tech. 2019;5(1):31–4. https://doi.org/10.1016/j.jvscit.2018.09.008.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Le Hello C, Auboire L, Berger L, Gouicem D, Barrellier MT, Duthois S. Symptomatic lower-limb giant-cell arteritis: characteristics, management and long-term outcome. J Med Vasc. 2017;42(3):148–56. https://doi.org/10.1016/j.jdmv.2017.03.001.

    Article  PubMed  Google Scholar 

  44. Godoy P, Araujo Sde A, Paulino E Jr, Lana-Peixoto MA. Coronary giant cell arteritis and acute myocardial infarction. Arq Bras Cardiol. 2007;88(4):e84–7. https://doi.org/10.1590/s0066-782x2007000400027.

    Article  PubMed  Google Scholar 

  45. Jang JJ, Gorevic PD, Olin JW. Images in vascular medicine. Giant cell arteritis presenting with acute myocardial infarction. Vasc Med. 2007;12(4):379. https://doi.org/10.1177/1358863X07083176.

    Article  PubMed  Google Scholar 

  46. Goodson N. Coronary artery disease and rheumatoid arthritis. Curr Opin Rheumatol. 2002;14(2):115–20. https://doi.org/10.1097/00002281-200203000-00007.

    Article  PubMed  Google Scholar 

  47. Zeller CB, Appenzeller S. Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. Curr Cardiol Rev. 2008;4(2):116–22. https://doi.org/10.2174/157340308784245775.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Ungprasert P, Koster MJ, Warrington KJ. Coronary artery disease in giant cell arteritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2015;44(5):586–91. https://doi.org/10.1016/j.semarthrit.2014.10.010.

    Article  PubMed  Google Scholar 

  49. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore). 2005;84(5):269–76. https://doi.org/10.1097/01.md.0000180042.42156.d1.

    Article  Google Scholar 

  50. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Gomez-Acebo I, Pego-Reigosa R, Lopez-Diaz MJ, Vazquez-Trinanes MC, et al. Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis. Medicine (Baltimore). 2009;88(4):227–35. https://doi.org/10.1097/MD.0b013e3181af4518.

    Article  Google Scholar 

  51. Samson M, Jacquin A, Audia S, Daubail B, Devilliers H, Petrella T, et al. Stroke associated with giant cell arteritis: a population-based study. J Neurol Neurosurg Psychiatry. 2015;86(2):216–21. https://doi.org/10.1136/jnnp-2014-307614.

    Article  PubMed  Google Scholar 

  52. Ungprasert P, Wijarnpreecha K, Koster MJ, Thongprayoon C, Warrington KJ. Cerebrovascular accident in patients with giant cell arteritis: a systematic review and meta-analysis of cohort studies. Semin Arthritis Rheum. 2016;46(3):361–6. https://doi.org/10.1016/j.semarthrit.2016.07.005.

    Article  PubMed  Google Scholar 

  53. de Boysson H, Liozon E, Lariviere D, Samson M, Parienti JJ, Boutemy J, et al. Giant cell arteritis-related stroke: a retrospective multicenter case-control study. J Rheumatol. 2017;44(3):297–303. https://doi.org/10.3899/jrheum.161033.

    Article  PubMed  Google Scholar 

  54. Pfadenhauer K, Esser M, Berger K. Vertebrobasilar ischemia and structural abnormalities of the vertebral arteries in active temporal arteritis and polymyalgia rheumatica--an ultrasonographic case-control study. J Rheumatol. 2005;32(12):2356–60.

    PubMed  Google Scholar 

  55. Alsolaimani RS, Bhavsar SV, Khalidi NA, Pagnoux C, Mandzia JL, Tay K, et al. Severe intracranial involvement in giant cell arteritis: 5 cases and literature review. J Rheumatol. 2016;43(3):648–56. https://doi.org/10.3899/jrheum.150143.

    Article  PubMed  Google Scholar 

  56. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I4–8. https://doi.org/10.1161/01.CIR.0000078468.11849.66.

    Article  PubMed  Google Scholar 

  57. Carson JL, Kelley MA, Duff A, Weg JG, Fulkerson WJ, Palevsky HI, et al. The clinical course of pulmonary embolism. N Engl J Med. 1992;326(19):1240–5. https://doi.org/10.1056/NEJM199205073261902.

    Article  CAS  PubMed  Google Scholar 

  58. Tamaki H, Khasnis A. Venous thromboembolism in systemic autoimmune diseases: a narrative review with emphasis on primary systemic vasculitides. Vasc Med. 2015;20(4):369–76. https://doi.org/10.1177/1358863X15573838.

    Article  PubMed  Google Scholar 

  59. Ungprasert P, Koster MJ, Thongprayoon C, Warrington KJ. Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis. Clin Rheumatol. 2016;35(11):2741–7. https://doi.org/10.1007/s10067-016-3394-7.

    Article  PubMed  Google Scholar 

  60. Unizony S, Lu N, Tomasson G, Zhang Y, Merkel PA, Stone JH, et al. Temporal trends of venous thromboembolism risk before and after diagnosis of giant cell arteritis. Arthritis Rheum. 2017;69(1):176–84. https://doi.org/10.1002/art.39847.

    Article  CAS  Google Scholar 

  61. Durand M, Thomas SL. Incidence of infections in patients with giant cell arteritis: a cohort study. Arthritis Care Res. 2012;64(4):581–8. https://doi.org/10.1002/acr.21569.

    Article  Google Scholar 

  62. Mohammad AJ, Englund M, Turesson C, Tomasson G, Merkel PA. Rate of comorbidities in giant cell arteritis: a population-based study. J Rheumatol. 2017;44(1):84–90. https://doi.org/10.3899/jrheum.160249.

    Article  PubMed  Google Scholar 

  63. Wu J, Keeley A, Mallen C, Morgan AW, Pujades-Rodriguez M. Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England. CMAJ. 2019;191(25):E680–E8. https://doi.org/10.1503/cmaj.190178.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Udayakumar PD, Chandran AK, Crowson CS, Warrington KJ, Matteson EL. Hospitalized infections in giant cell arteritis: a population-based retrospective cohort study. J Rheumatol. 2014;41(12):2447–51. https://doi.org/10.3899/jrheum.140124.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Schmidt J, Smail A, Roche B, Gay P, Salle V, Pellet H, et al. Incidence of severe infections and infection-related mortality during the course of giant cell arteritis: a multicenter, prospective. Double-Cohort Study. Arthritis Rheumatol. 2016;68(6):1477–82. https://doi.org/10.1002/art.39596.

    Article  CAS  PubMed  Google Scholar 

  66. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc. 1996;71(1):5–13. https://doi.org/10.4065/71.1.5.

    Article  CAS  PubMed  Google Scholar 

  67. Berger CT, Greiff V, John S, Koenig KF, Bigler MB, Recher M, et al. Risk factors for pneumocystis pneumonia in giant cell arteritis: a single-centre cohort study. Clin Exp Rheumatol. 2015;33(2 Suppl 89):S-122–5.

    Google Scholar 

  68. Kermani TA, Ytterberg SR, Warrington KJ. Pneumocystis jiroveci pneumonia in giant cell arteritis: a case series. Arthritis Care Res. 2011;63(5):761–5. https://doi.org/10.1002/acr.20435.

    Article  Google Scholar 

  69. Park JW, Curtis JR, Moon J, Song YW, Kim S, Lee EB. Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids. Ann Rheum Dis. 2018;77(5):644–9. https://doi.org/10.1136/annrheumdis-2017-211796.

    Article  CAS  PubMed  Google Scholar 

  70. Ungprasert P, Sanguankeo A, Upala S, Knight EL. Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis. Semin Arthritis Rheum. 2014;44(3):366–70. https://doi.org/10.1016/j.semarthrit.2014.06.004.

    Article  PubMed  Google Scholar 

  71. Stamatis P, Turesson C, Willim M, Nilsson JA, Englund M, Mohammad AJ. Malignancies in giant cell arteritis: a population-based cohort study. J Rheumatol. 2020;47(3):400–6. https://doi.org/10.3899/jrheum.190236.

    Article  PubMed  Google Scholar 

  72. Brekke LK, Fevang BS, Diamantopoulos AP, Assmus J, Espero E, Gjesdal CG. Risk of cancer in 767 patients with giant cell arteritis in Western Norway: a retrospective cohort with matched controls. J Rheumatol. 2020;47(5):722–9. https://doi.org/10.3899/jrheum.190147.

    Article  PubMed  Google Scholar 

  73. Hill CL, Black RJ, Nossent JC, Ruediger C, Nguyen L, Ninan JV, et al. Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2017;46(4):513–9. https://doi.org/10.1016/j.semarthrit.2016.08.015.

    Article  PubMed  Google Scholar 

  74. Kermani TA, Warrington KJ, Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE, et al. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis. 2013;72(12):1989–94. https://doi.org/10.1136/annrheumdis-2012-202408.

    Article  PubMed  Google Scholar 

  75. Sanchez-Alvarez C, Mertz LE, Thomas CS, Cochuyt JJ, Abril A. Demographic, clinical, and radiologic characteristics of a cohort of patients with Takayasu arteritis. Am J Med. 2019;132(5):647–51. https://doi.org/10.1016/j.amjmed.2018.12.017.

    Article  PubMed  Google Scholar 

  76. Yang L, Zhang H, Jiang X, Zou Y, Qin F, Song L, et al. Clinical manifestations and longterm outcome for patients with Takayasu arteritis in China. J Rheumatol. 2014;41(12):2439–46. https://doi.org/10.3899/jrheum.140664.

    Article  PubMed  Google Scholar 

  77. Esen F, Ergelen R, Alibaz-Oner F, Celik G, Direskeneli H, Kazokoglu H. Ocular findings and blood flow in patients with Takayasu arteritis: a cross-sectional study. Br J Ophthalmol. 2019;103(7):928–32. https://doi.org/10.1136/bjophthalmol-2018-312580.

    Article  PubMed  Google Scholar 

  78. •• Aeschlimann FA, Barra L, Alsolaimani R, Benseler SM, Hebert D, Khalidi N, et al. Presentation and disease course of childhood-onset versus adult-onset takayasu arteritis. Arthritis Rheum. 2019;71(2):315–23. https://doi.org/10.1002/art.40690This study provides a thorough comparison between the clinical, radiographic findings between adult- and child-onset Takayasu arteritis and discusses the observed differences in disease outcomes.

    Article  Google Scholar 

  79. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919–29. https://doi.org/10.7326/0003-4819-120-11-199406010-00004.

    Article  CAS  PubMed  Google Scholar 

  80. Soto ME, Espinola N, Flores-Suarez LF, Reyes PA. Takayasu arteritis: clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol. 2008;26(3 Suppl 49):S9–15.

    CAS  PubMed  Google Scholar 

  81. Schmidt J, Kermani TA, Bacani AK, Crowson CS, Cooper LT, Matteson EL, et al. Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin Proc. 2013;88(8):822–30. https://doi.org/10.1016/j.mayocp.2013.04.025.

    Article  PubMed  Google Scholar 

  82. Bond KM, Nasr D, Lehman V, Lanzino G, Cloft HJ, Brinjikji W. Intracranial and extracranial neurovascular manifestations of Takayasu arteritis. AJNR Am J Neuroradiol. 2017;38(4):766–72. https://doi.org/10.3174/ajnr.A5095.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Yang KQ, Meng X, Zhang Y, Fan P, Wang LP, Zhang HM, et al. Aortic aneurysm in Takayasu arteritis. Am J Med Sci. 2017;354(6):539–47. https://doi.org/10.1016/j.amjms.2017.08.018.

    Article  PubMed  Google Scholar 

  84. Zhang Y, Yang K, Meng X, Tian T, Fan P, Zhang H, et al. Cardiac valve involvement in Takayasu arteritis is common: a retrospective study of 1,069 patients over 25 years. Am J Med Sci. 2018;356(4):357–64. https://doi.org/10.1016/j.amjms.2018.06.021.

    Article  PubMed  Google Scholar 

  85. Aeschlimann FA, Eng SWM, Sheikh S, Laxer RM, Hebert D, Noone D, et al. Childhood Takayasu arteritis: disease course and response to therapy. Arthritis Res Ther. 2017;19(1):255. https://doi.org/10.1186/s13075-017-1452-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Wang J, Lee YZ, Cheng Y, Zheng Y, Gao J, Tang X, et al. Sonographic characterization of arterial dissections in Takayasu arteritis. J Ultrasound Med. 2016;35(6):1177–91. https://doi.org/10.7863/ultra.15.07042.

    Article  CAS  PubMed  Google Scholar 

  87. Soto ME, Melendez-Ramirez G, Kimura-Hayama E, Meave-Gonzalez A, Achenbach S, Herrera MC, et al. Coronary CT angiography in Takayasu arteritis. JACC Cardiovasc Imaging. 2011;4(9):958–66. https://doi.org/10.1016/j.jcmg.2011.04.019.

    Article  PubMed  Google Scholar 

  88. Comarmond C, Dessault O, Devaux JY, Costedoat-Chalumeau N, Resche-Rigon M, Isnard R, et al. Myocardial perfusion imaging in Takayasu arteritis. J Rheumatol. 2013;40(12):2052–60. https://doi.org/10.3899/jrheum.130308.

    Article  PubMed  Google Scholar 

  89. Comarmond C, Biard L, Lambert M, Mekinian A, Ferfar Y, Kahn JE, et al. Long-term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients. Circulation. 2017;136(12):1114–22. https://doi.org/10.1161/CIRCULATIONAHA.116.027094.

    Article  PubMed  Google Scholar 

  90. Toledano K, Guralnik L, Lorber A, Ofer A, Yigla M, Rozin A, et al. Pulmonary arteries involvement in Takayasu’s arteritis: two cases and literature review. Semin Arthritis Rheum. 2011;41(3):461–70. https://doi.org/10.1016/j.semarthrit.2011.06.001.

    Article  PubMed  Google Scholar 

  91. Lupi E, Sanchez G, Horwitz S, Gutierrez E. Pulmonary artery involvement in Takayasu’s arteritis. Chest. 1975;67(1):69–74. https://doi.org/10.1378/chest.67.1.69.

    Article  CAS  PubMed  Google Scholar 

  92. Yang J, Peng M, Shi J, Zheng W, Yu X. Pulmonary artery involvement in Takayasu’s arteritis: diagnosis before pulmonary hypertension. BMC Pulm Med. 2019;19(1):225. https://doi.org/10.1186/s12890-019-0983-7.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Brennan DN, Warrington KJ, Crowson CS, Schmidt J, Koster MJ. Cardiopulmonary involvement in Takayasu’s arteritis. Clin Exp Rheumatol. 2018;36(Suppl 111(2)):46–50.

    PubMed  Google Scholar 

  94. Vanoli M, Daina E, Salvarani C, Sabbadini MG, Rossi C, Bacchiani G, et al. Takayasu’s arteritis: a study of 104 Italian patients. Arthritis Rheum. 2005;53(1):100–7. https://doi.org/10.1002/art.20922.

    Article  CAS  PubMed  Google Scholar 

  95. Arnaud L, Haroche J, Limal N, Toledano D, Gambotti L, Costedoat Chalumeau N, et al. Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, North African, and black patients. Medicine (Baltimore). 2010;89(1):1–17. https://doi.org/10.1097/MD.0b013e3181cba0a3.

    Article  PubMed  Google Scholar 

  96. Hong S, Ghang B, Kim YG, Lee CK, Yoo B. Longterm outcomes of renal artery involvement in Takayasu arteritis. J Rheumatol. 2017;44(4):466–72. https://doi.org/10.3899/jrheum.160974.

    Article  PubMed  Google Scholar 

  97. Zheng T, Zhu S, Ou JF, Fang WG, Qiao ZY, Qi RD, et al. Treatment with corticosteroid and/or immunosuppressive agents before surgery can effectively improve the surgical outcome in patients with Takayasu’s arteritis. J Investig Surg. 2019;32(3):220–7. https://doi.org/10.1080/08941939.2017.1408718.

    Article  Google Scholar 

  98. Liang P, Tan-Ong M, Hoffman GS. Takayasu’s arteritis: vascular interventions and outcomes. J Rheumatol. 2004;31(1):102–6.

    PubMed  Google Scholar 

  99. Yang Y, Tian T, Yang K, Zhang Y, Meng X, Fan P, et al. Outcomes of percutaneous coronary intervention and coronary artery bypass grafting in patients with Takayasu arteritis. Int J Cardiol. 2017;241:64–9. https://doi.org/10.1016/j.ijcard.2017.02.041.

    Article  PubMed  Google Scholar 

  100. Labarca C, Makol A, Crowson CS, Kermani TA, Matteson EL, Warrington KJ. Retrospective comparison of open versus endovascular procedures for Takayasu arteritis. J Rheumatol. 2016;43(2):427–32. https://doi.org/10.3899/jrheum.150447.

    Article  CAS  PubMed  Google Scholar 

  101. Fields CE, Bower TC, Cooper LT, Hoskin T, Noel AA, Panneton JM, et al. Takayasu’s arteritis: operative results and influence of disease activity. J Vasc Surg. 2006;43(1):64–71. https://doi.org/10.1016/j.jvs.2005.10.010.

    Article  PubMed  Google Scholar 

  102. Couture P, Chazal T, Rosso C, Haroche J, Leger A, Hervier B, et al. Cerebrovascular events in Takayasu arteritis: a multicenter case-controlled study. J Neurol. 2018;265(4):757–63. https://doi.org/10.1007/s00415-018-8744-8.

    Article  PubMed  Google Scholar 

  103. Fan L, Zhang H, Cai J, Yang L, Liu B, Wei D, et al. Clinical course and prognostic factors of childhood Takayasu’s arteritis: over 15-year comprehensive analysis of 101 patients. Arthritis Res Ther. 2019;21(1):31. https://doi.org/10.1186/s13075-018-1790-x.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Szugye HS, Zeft AS, Spalding SJ. Takayasu arteritis in the pediatric population: a contemporary United States-based single center cohort. Pediatr Rheumatol Online J. 2014;12:21. https://doi.org/10.1186/1546-0096-12-21.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Eleftheriou D, Varnier G, Dolezalova P, McMahon AM, Al-Obaidi M, Brogan PA. Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom. Arthritis Res Ther. 2015;17:36. https://doi.org/10.1186/s13075-015-0545-1.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Comarmond C, Mirault T, Biard L, Nizard J, Lambert M, Wechsler B, et al. Takayasu arteritis and pregnancy. Arthritis Rheum. 2015;67(12):3262–9. https://doi.org/10.1002/art.39335.

    Article  CAS  Google Scholar 

  107. Kirshenbaum M, Simchen MJ. Pregnancy outcome in patients with Takayasu’s arteritis: cohort study and review of the literature. J Matern Fetal Neonatal Med. 2018;31(21):2877–83. https://doi.org/10.1080/14767058.2017.1359529.

    Article  PubMed  Google Scholar 

  108. Park SJ, Kim HJ, Park H, Hann HJ, Kim KH, Han S, et al. Incidence, prevalence, mortality and causes of death in Takayasu arteritis in Korea - a nationwide, population-based study. Int J Cardiol. 2017;235:100–4. https://doi.org/10.1016/j.ijcard.2017.02.086.

    Article  PubMed  Google Scholar 

  109. Mirouse A, Biard L, Comarmond C, Lambert M, Mekinian A, Ferfar Y, et al. Overall survival and mortality risk factors in Takayasu’s arteritis: a multicenter study of 318 patients. J Autoimmun. 2019;96:35–9. https://doi.org/10.1016/j.jaut.2018.08.001.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Division of Rheumatology, Mayo Clinic College of Medicine and Science, 200 1st Street SW, Rochester, MN, 55905, USA

    Matthew J. Koster, Kenneth J. Warrington & Eric L. Matteson

Authors
  1. Matthew J. Koster
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth J. Warrington
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eric L. Matteson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew J. Koster.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Recent Advances in Large Vessel Vasculitis

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Koster, M.J., Warrington, K.J. & Matteson, E.L. Morbidity and Mortality of Large-Vessel Vasculitides. Curr Rheumatol Rep 22, 86 (2020). https://doi.org/10.1007/s11926-020-00963-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11926-020-00963-y

Keywords

Search

Navigation